VIM and Parkinson disease: The reduced mitochondrial potential in vimentin-null cells may parallel the mitochondrial impairments seen in conditions like Parkinson’s disease or amyotrophic lateral sclerosis (ALS), where mitochondrial bioenergetics are often compromised.